Transcatheter Mitral Valve Implantation (TMVI) Devices (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021
This Medical Devices sector report, “Transcatheter Mitral Valve Implantation (TMVI) Devices (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Transcatheter Mitral Valve Implantation (TMVI) Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Transcatheter Heart Valve is a artificial heart valve made up of natural tissue (biological material mainly derived from cow or bovine) surrounded by a flexible mesh frame known as stent (made of steel or cobalt-chromium), all placed in a long narrow tube known as a catheter. The catheter is inserted into a large blood vessel in the groin area (transfemoral) or through a small incision in chest (transapical). Once inside the heart, the valve can then be opened into its natural position by inflation of a balloon and deployed within the patient's diseased mitral valve.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The report enables you to -
Summary
This Medical Devices sector report, “Transcatheter Mitral Valve Implantation (TMVI) Devices (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Transcatheter Mitral Valve Implantation (TMVI) Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Transcatheter Heart Valve is a artificial heart valve made up of natural tissue (biological material mainly derived from cow or bovine) surrounded by a flexible mesh frame known as stent (made of steel or cobalt-chromium), all placed in a long narrow tube known as a catheter. The catheter is inserted into a large blood vessel in the groin area (transfemoral) or through a small incision in chest (transapical). Once inside the heart, the valve can then be opened into its natural position by inflation of a balloon and deployed within the patient's diseased mitral valve.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Transcatheter Mitral Valve Implantation (TMVI) Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Transcatheter Mitral Valve Implantation (TMVI) Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Transcatheter Mitral Valve Implantation (TMVI) Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Transcatheter Mitral Valve Implantation (TMVI) Devices - Pipeline Products under Development by Companies
5 Transcatheter Mitral Valve Implantation (TMVI) Devices Companies and Product Overview
6 Transcatheter Mitral Valve Implantation (TMVI) Devices- Recent Developments
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 4C Medical Technologies Inc
- Abbott Vascular Inc
- Annulon
- Cardiovalve Ltd
- Cephea Valve Technologies, Inc.
- Colibri Heart Valve LLC
- Direct Flow Medical Inc (Inactive)
- Edwards Lifesciences Corp
- Emory University
- Foldax Inc
- LivaNova PLC
- Medtronic Plc
- Micro Interventional Devices, Inc.
- MicroPort CardioFlow Medtech Corp
- MitrAssist Ltd.
- MValve Technologies Ltd.
- Neovasc Inc
- NewMed Medical Co Ltd
- P+F Products + Features GmbH
- Polares Medical SA
- Sino Medical Sciences Technology Inc
- Symetis SA
- Tioga Medical Inc
- Trinity College Dublin
- University College London
- Valcare Medical
- Venus MedTech
